VF
RPRX

Virtu Financial’s Repros Therapeutics Inc. RPRX Stock Holding History

Virtu Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-132,445
Closed -$42K – 3489
2017
Q3 		$42K Buy
+132,445
New +$46.5K ﹤0.01% 2251

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's RPRX Position: Q4 2017 in Review

Virtu Financial sold out of Repros Therapeutics Inc. (RPRX) in Q4 2017, closing a stake of 132,445 shares — an estimated $42K sold.

Virtu Financial first reported a position in RPRX in Q3 2017 and held it in 1 quarter. The position peaked at $42K in Q3 2017. 30 funds tracked by Wall St. Rank hold RPRX as of Q4 2017.

  • Virtu Financial reported no remaining Repros Therapeutics Inc. position as of Q4 2017 after selling out during the quarter.
  • Virtu Financial sold 132,445 Repros Therapeutics Inc. shares in Q4 2017, an estimated $42K.
  • Virtu Financial first reported a position in Repros Therapeutics Inc. in Q3 2017 and held it in 1 quarter.
  • Virtu Financial's Repros Therapeutics Inc. position peaked at $42K in Q3 2017.
  • 30 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2017.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.